
Opinion|Videos|March 17, 2025
Friedreich Ataxia: Pathophysiology, Prevalence, and Prognosis
Author(s)David R. Lynch, MD, PhD
An expert discusses how Friedreich ataxia is an autosomal recessive neurodegenerative disorder caused by trinucleotide (GAA) repeat expansion in the FXN gene, reducing frataxin protein production. This leads to mitochondrial dysfunction and progressive damage to the spinal cord, peripheral nerves, and heart. Patients present with progressive ataxia, dysarthria, sensory loss, and areflexia, typically manifesting between ages 5 and 15. Diagnosis relies on clinical assessment, genetic testing for GAA expansions, and supportive findings, including cardiomyopathy, scoliosis, and diabetes.
Advertisement
Video content above is prompted by the following:
- Briefly describe the pathophysiology of Friedreich ataxia and its associated symptoms.
- How is Friedreich ataxia clinically diagnosed, and when do patients present to clinic?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Ublituximab Meets Primary End Point in Phase 3 ENHANCE Trial for Relapsing Multiple Sclerosis
2
Introducing The G.L.O.B: Dr. Gatson's Neuro-Oncology Column
3
Curving Cognitive Decline in Epilepsy: Introducing Cleveland Clinic’s New HAP-E Pilot Program
4
Integrating Clinical Research Insights Into Multiple Sclerosis Practice: Mark Freedman, MD, MSc
5


















